Latest Brain tumor Stories
Following an article about brain cancer patient Iram Leon winning the Gusher Marathon, Voices Against Brain Cancer (VABC) issues a statement. New York, NY (PRWEB) April 15, 2013 On April 15, 2013, Voices Against Brain Cancer commends Iram Leon following a Beaumont Enterprise article discussing Leon's win at a marathon while pushing his 6-year-old daughter Kiana in a stroller. The Beaumont Enterprise article stated that Iram Leon won the Gusher marathon in 3 hours, 7 minutes, and 35...
The St. Jude Children's Research Hospital -- Washington University Pediatric Cancer Genome Project advances understanding of genetic defects underlying childhood low-grade gliomas and identifies promising new drug therapies The St. Jude Children's Research Hospital – Washington University Pediatric Cancer Genome Project has identified mutations responsible for more than half of a subtype of childhood brain tumor that takes a high toll on patients. Researchers also found evidence the...
The St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project advances understanding of genetic defects underlying childhood low-grade gliomas and identifies promising new drug therapies MEMPHIS, Tenn., April 14, 2013 /PRNewswire-USNewswire/ -- The St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project has identified mutations responsible for more than half of a subtype of childhood brain tumor that takes a...
First-of-its-kind disease funding schemas provide a comprehensive view of neurofibromatosis research PHILADELPHIA, April 10, 2013 /PRNewswire/ -- The Intellectual Property & Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals, today announced a partnership with the Children's Tumor Foundation (CTF), to further the understanding of neurofibromatosis (NF) research by creating schemas that visually...
An irregularity within many neuroblastoma cells may indicate whether a neuroblastoma tumor, a difficult-to-treat, early childhood cancer, is vulnerable to a new class of anti-cancer drugs known as BET bromodomain inhibitors, Dana-Farber/Children's Hospital Cancer Center scientists will report at the annual meeting of the American Association for Cancer Research in Washington, April 6-10. The findings (abstract 4622) will be discussed in a minisymposium on Tuesday, April 9, 3:50 - 4:05...
VANCOUVER, British Columbia and MENLO PARK, Calif., April 10, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) today announced additional positive interim data from an ongoing Phase I/II clinical trial of VAL-083 in patients with recurrent glioblastoma multiforme (GBM) or progressive secondary brain tumor. The data are being presented at the American Association for Cancer Research (AACR) Annual Meeting in Washington, D.C. during a clinical poster session entitled,...
Voices Against Brain Cancer (VABC) announces first annual “Join the Voices!” charity walk and run in Chicago to raise funds for brain cancer and brain tumor research. Illinois residents and members of the medical community will be honored at the event. Bohemia, NY (PRWEB) April 08, 2013 Voices Against Brain Cancer will host the first annual “Join the Voices! Chicago Run/Walk” on Sunday, May 5, 2013 in Lincoln Park, Chicago at 8 a.m. The charitable event will feature a 5K run, a...
BETHESDA, Md., April 8, 2013 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax(®) personalized immune therapies for solid tumor cancers, filed its annual report on Form 10K today, reporting its financial results for the year ended December 31, 2012. The report also shows strong progress in all areas of the Company's operations, enhancing the Company's leadership position in immune therapies for cancer. (Logo:...
Voices Against Brain Cancer (VABC) responds to an article posted by Bioscience Technology detailing how the blockage of molecular pathways in the brain may be a contributing factor to the development of brain tumors. Bohemia, NY (PRWEB) April 05, 2013 On April 5, 2013, Voices Against Brain Cancer (VABC) responds to an article posted by Bioscience Technology detailing how the blockage of molecular pathways in the brain could be a contributing factor in the development of brain tumors. The...
Neurosurgeons find new treatment for glioblastoma safe; opens door for larger study CLEVELAND, April 5, 2013 /PRNewswire/ -- The first-in-human study of the NeuroBlate(TM) Thermal Therapy System finds that it appears to provide a new, safe and minimally invasive procedure for treating recurrent glioblastoma (GBM), a malignant type of brain tumor. The study, which appears April 5 in the Journal of Neurosurgery online, was written by lead author Andrew Sloan, MD, director of...
